Corbus Pharmaceuticals
Focus: Corbus Pharmaceuticals is a specialty biopharmaceutical company focused on orphan inflammatory-fibrotic diseases, headquartered in Norwood, MA with a pipeline spanning immunology, neurology, and rare diseases.
Profile data last refreshed 10h ago · AI intelligence enriched 2w ago
Open Jobs
4-1 this month
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Should You Work at Corbus Pharmaceuticals?
AI assessmentBest suited for early-to-mid career scientists and clinical professionals comfortable with orphan-disease risk tolerance and seeking hands-on rare-disease expertise.
Why Work Here
- Focused pipeline in high-need rare disease areas with 10 active trials spanning Phase 1–3, including Phase 3 programs in dermatomyositis and diffuse cutaneous systemic sclerosis
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PHASE_1
Clinical Trials (1)
NCT07310901A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity
Phase 1Help build intelligence for Corbus Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.